MedWorm provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest medical blog items that have been tagged with 'dividends'. Sat, 03 Sep 2011 02:39:47 +0100 http://www.medworm.com/index.php?rid=4753666&cid=t_173128_87_f&fid=36438&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FCato-at-liberty%2F%7E3%2F3hDFR4atXeA%2F By Alan Reynolds“In the last decade, the average income of the bottom 90 percent of all working Americans actually declined,” Obama said on April 13. “The top 1 percent saw their income rise by an average of more than a quarter of a million dollars each.” Politi-Fact, partly on the basis of my own research, generously rates the president’s claim as “Half True.” The truth is that the President’s source, Thomas Piketty and Emmanuel Saez, refer only to pretax, pretransfer income reported on individual tax returns (as opposed to being sheltered inside a corporation or IRA or simply unreported), and they have no data on the bottom 90%. Worst of all, they leave out transfer payments, which amounted to $2.3 trillion last year — 44% as large as a... Cato-at-liberty blogs http://www.medworm.com/rss/comments.php?id=4753666 Tue, 26 Apr 2011 19:55:08 +0100 4753666 http://www.medworm.com/index.php?rid=4482741&cid=t_173128_87_f&fid=36438&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FCato-at-liberty%2F%7E3%2FL1MuKwILD7g%2F By Mark A. CalabriaOn Friday the Obama Administration released its report on "reforming America's Housing Finance Market."  The report claimed that the Administration would work toward "winding down Fannie Mae and Freddie Mac on a responsible timeline."  While the report was silent on what a responsible timeline would be (surprise, no details); I assumed, perhaps naively, that a reasonable timeline would be 5 to 6 years.  So you can imagine my surprise while reading the Administration's budget proposal (see Table S-12 of the summary tables), released Monday, that the Administration is projecting that the government will be receiving, between 2012 and 2021, $89 billion in dividend payments from Fannie Mae and Freddie Mac.  In 2021 alone the White House projects $8 billion in dividend p... Cato-at-liberty blogs http://www.medworm.com/rss/comments.php?id=4482741 Wed, 16 Feb 2011 14:18:18 +0100 4482741 http://www.medworm.com/index.php?rid=4433326&cid=t_173128_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FMU6LJ6WAdvA%2F Pleasing Wall Street is never easy, but consider the contrast between Merck and Pfizer. Earlier this week, Pfizer disclosed plans to cut R&D spending by $1.5 billion - a move that involves closing a facility and eliminating up 3,500 jobs - and buying back $5 billion worth of stock. Investors promptly reacted by sending Pfizer shares to a 52-week high. Why? The take-away message was two-fold: Pfizer was maintaining a comfortable 4.4 percent yield on the dividend, and the long-term strategy hinges on the drugmaker focusing research only on certain therapeutic areas. In fact, Pfizer has been using such tactics for the past few years, even before the Wyeth acquisition. Then, there’s Merck, which withdrew its earnings forecast of high single-digit growth through 2013. Why? Two previo... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=4433326 Thu, 03 Feb 2011 17:59:36 +0100 4433326 http://www.medworm.com/index.php?rid=3671975&cid=t_173128_136_f&fid=37852&url=http%3A%2F%2Fdonnatrussell.com%2F2010%2F06%2F18%2Foil-leak-and-bp-the-brits-take-tea%2F New cartoon by Trussell & Trussell on Politics Daily. Oil Leak and BP: The Brits Take Tea. Filed under: Politics Daily Tagged: bp, british, brits, chaos theory, dividends, oil spill, political cartoon (Source: Donna Trussell) Donna Trussell blogs http://www.medworm.com/rss/comments.php?id=3671975 Fri, 18 Jun 2010 05:07:32 +0100 3671975 http://www.medworm.com/index.php?rid=3599738&cid=t_173128_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FOgrZm0fTE7A%2F Rise and shine. Another day awaits. And who knows what lies ahead? Meetings? Deadlines? Unexpected tidbits of information? We can relate. So grab a cup of stimulation - or perhaps, a bottle of water, since it will be rather sticky today in the greater Pharmalot metropolitan region - and dive in. As always, here are some items to ease the process. Have a great day everyone and stay in touch… UK’s NICE Won’t Cover Bayer Liver Cancer Drug (Bloomberg News) AMRI Cuts US Workforce 10% And Shifts Jobs To Asia (OutsourcingPharma) FTC Commish Remains Bullish On Ending Pay-To-Delay Deals (PharmaTimes) Dennis Quaid Sues Baxter Over Heparin Overdose (USA Today) Merck Will Not Raise Its Dividend (Associated Press) Sanofi-Aventis Will Reassign Global Media Ad Duties (MM&M) Photo t... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=3599738 Wed, 26 May 2010 11:48:29 +0100 3599738 http://www.medworm.com/index.php?rid=2648964&cid=t_173128_87_f&fid=36438&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FCato-at-liberty%2F%7E3%2F21KAs7jsxn4%2F There seems to be near universal agreement that the excessive use of debt among both corporations, particularly banks, and households contributed to the severity of the financial crisis.  However, other than the occasional refrain that banks should hold more capital, there has been little discussion over why corporations choose to be so highly leveraged in the first place.  But then such a discussion might lead us to the all too obvious answer — the federal government, via the tax code, encourages, even heavily subsidizes corporate leverage. Cato scholar and banking analyst Bert Ely has estimated that the subsides for debt have historically resulted in an after tax cost of debt of 3 to 5 percent, compared to an after tax cost of equity of 12 to 15 percent.  With differences of th... Cato-at-liberty blogs http://www.medworm.com/rss/comments.php?id=2648964 Tue, 28 Jul 2009 20:53:32 +0100 2648964 http://www.medworm.com/index.php?rid=2047640&cid=t_173128_150_f&fid=35777&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F486580527%2F After 41 years of regularly increasing its dividend, the beleaguered drugmaker has kept the payout steady at 32 cents a share as it looks to preserve cash in the face of the looming Lipitor patent expiration in 2011. Pfizer ceo Jeff Kindler actually signaled recently that the dividend would, at the least, be maintained. Some may find the move disappointing, but of course, this is not the same thing as reducing the payout, which some Wall Streeters earlier this year thought would occur. Why? The $8 billion in dividend payments Pfizer made to shareholders last year is widely considered to be the biggest reason many investors still hold the stock. Put another way - Pfizer shares aren’t attractive for the pipeline. To maintain the payout, some analysts speculated Pfizer may have to repat... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=2047640 Tue, 16 Dec 2008 12:59:08 +0100 2047640 http://www.medworm.com/index.php?rid=1593969&cid=t_173128_109_f&fid=35677&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBrainBasedBusiness%2F%7E3%2F329092698%2F5_ds_to_mental_dividends.html Five side streets lead to remarkable mental dividends that can be easily bypassed on today's conjested, fast-paced business highways. Ready to shift pace for a smoother ride? Try five mental gears that increase brainpower and efficiency at the same time:1. Difficult: Challenges stretch and exercise your brain, like hiking or swimming build bodily well-being. The opposite is also true, brainpower shrinks with lack of new challenges.   2. Different: Diversity ratchets up mental power and in turn can lift your firm’s bottom line. Why then do so many firms miss diversity’s benefits?  Look for a new way to work, invite a person from another culture to lunch, or wear a color you rarely wear, and you’ve already stepped i... BrainBasedBusiness blogs http://www.medworm.com/rss/comments.php?id=1593969 Mon, 07 Jul 2008 19:12:48 +0100 1593969 http://www.medworm.com/index.php?rid=1492329&cid=t_173128_150_f&fid=35777&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F303706650%2F This is a question that won’t go away and it keeps Frank D’Amelio, the drugmaker’s cfo, very busy. For the past few months, a growing number of analysts have openly questioned whether the payout can continue and this morning, The Wall Street Journal takes another whack at the issue. The $8 billion in dividend payments Pfizer made to shareholders last year is, as the paper writes, widely considered to be among the few reasons many investors still hold the stock. Put another way - the stock isn’t attractive for its pipeline or patent expirations. At 6.67 percent, the yield is far superior to the pharma average of 3.37 percent and 2.18 percent for the S&P 500, the paper points out. Pfizer’s board is keeping a close eye on the ability to maintain the dividend... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=1492329 Tue, 03 Jun 2008 12:59:14 +0100 1492329 http://www.medworm.com/index.php?rid=1383778&cid=t_173128_150_f&fid=35777&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F273178512%2F After the poor quarterly earnings reported this week, the question is still very much on the table. You may recall that Pfizer’s dividend offers a yield of about 6 percent, an attractive amount that may be in danger due to the soon-to-expire Lipitor patents. To maintain the payout, some Wall Streeters speculate that Pfizer may have to repatriate off-shore cash, driving up its tax rate. Why? Lipitor contributed 65 percent of Pfizer’s free cash flow last year. This is an issue, because the dividend can only be paid from US funds. As Credit Suisse analyst Catherine Arnold has noted previously, repatriation rules prohibit the transfer of offshore earnings to the US without generating a tax liability. And as Lipitor patents begin to expire in 2010, cash flow starts to shrink - to less t... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=1383778 Sat, 19 Apr 2008 03:13:34 +0100 1383778 http://www.medworm.com/index.php?rid=1291153&cid=t_173128_150_f&fid=35777&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F248861386%2F That’s what one Wall Street analyst writes following Pfizer’s not-so-exciting briefing for big investors last week. In her 77-page report, Credit Suisse analyst Catherine Arnold argues the dividend, which offers a handsome 5.8 percent yield, may be in danger due to the soon-to-expire Lipitor patents. And to maintain the payout, Pfizer may have to repatriate off-shore cash, driving up its tax rate. Here’s why: Lipitor contributed 65 percent of Pfizer’s free cash flow last year. This is an issue, you see, because the dividend can only be paid from US funds. Repatriation rules, she notes, prohibit the transfer of offshore earnings to the US without generating a tax liability. And as Lipitor patents begin to expire in 2010, cash flow starts to shrink - to less than 30 p... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=1291153 Mon, 10 Mar 2008 13:07:32 +0100 1291153